Rocket Lab's Neutron Rocket Slips to 2027 After Carbon-Composite Flaw, and Analysts Are Repricing the Wait

Rocket Lab shares fell 8.2 percent on Friday, closing at EUR 45.25 in German trading, after the company disclosed that the maiden flight of its Neutron launch vehicle — previously targeted for the end of the year — will now slip into 2027. The stock's retreat leaves it 66 percent below its 52-week high, a gap that lays bare how little tolerance investors now have for operational surprises in the commercial space sector.

The delay traces back to material findings at the forward dome of the first stage's fuel tank. Internal inspections uncovered air pockets within the carbon-fiber layers of the structure. Rocket Lab was quick to point out that such a defect would not necessarily cause a loss in flight, but it does fall short of the company's own safety standards. Management halted work, revised the manufacturing process, and ordered the affected section rebuilt.

That decision carries its own logic. A failure on the launch pad would weigh far more heavily than a scheduling delay during development, and pressing ahead to hold the original fourth-quarter 2026 target would have put the entire heavy-lift program at risk. The first flight now set for 2027 is bitter news for near-term sentiment, yet it shields the company's underlying substance from far graver setbacks.

Two Houses, Two Targets, One Message

Analysts responded on October 15 with sharpened pencils rather than lost conviction. Goldman Sachs trimmed its price target to $67 from $75 while keeping a Neutral rating, citing expected additional costs and a noticeably higher cash burn over the coming quarters as development rounds stretch on. KeyBanc made the same-day adjustment, cutting its target to $100 from $135 but reaffirming its Overweight stance. The house pointed not only to the revised Neutron schedule but also to broader valuation pressure on high-growth space stocks — the era in which visionary promises commanded premium multiples without challenge has, for now, given way.

Other firms lowered their targets within a similar $90 to $122 range while remaining largely positive on the shares. The pattern is consistent: Wall Street is clipping valuation peaks, not questioning the business model.

A Sector Moving From Pioneering to Industrial Routine

Rocket Lab stands as a case study for an industry negotiating the passage from frontier ambition to industrial discipline. Space is among the most capital-intensive sectors there is, and its valuation premiums rest heavily on hitting milestones without major mishaps. When a build schedule slips, expected revenue shifts while development spending keeps running unabated — liquidity drains before the first paying payload ever leaves the pad.

Technical hurdles are par for the course in aerospace, and no operator can afford to rush a test flight when fundamental components need rework. Still, the market applies its own unforgiving arithmetic in such moments. Investors who once bought into strategic vision now demand hard evidence of reliable execution, and further delays are unlikely to be forgiven. The path to orbit requires precision from the engineers — and, for shareholders, a strong stomach for a drawn-out test of patience.